Hugo Geerts
In Silico Biosciences, University of Pennsylvania
USA
Biography
Hugo Geerts has spent 17 years in the (CNS) Drug Discovery Area, with Paul Janssen, probably the greatest drug hunters in history at the Janssen Research Foundation in Beerse, Belgium doing research in Alzheimer’s disease with targets in tangle and amyloid pathology. He was involved in supporting the successful preclinical, clinical and postmarketing development of galantamine. Since 2002, he became CSO of In Silico Biosciences, a company providing mathematical modeling of pathological interactions in the brain for supporting the whole process of drug discovery from target validation to clinical trial design in Psychiatry and Neurology. He is the faculty of the University of Pennsylvania, Perelman School of Medicine and Drexel Dept. of Pharmacology and has over 80 peer-reviewed publications and patents.
Research Interest